SAN DIEGO, July 31, 2014 (GLOBE NEWSWIRE) -- EHouse Global, Inc. (OTCBB:EHOS), (the "Company" or "EHouse") (www.EHouse-Global.com), an emerging specialty nutraceutical company with 16 liquid based nutritional products in the dietary supplement industry, is pleased to announce that the Company's S-1 Registration Statement originally filed with the US Securities and Exchange Commission ("SEC") May 27, 2014 for the securities to be sold under the investment agreement between the Company and Dutchess Opportunity Fund II, LLP has been declared effective. The Company intends to fund its initial inventory order with the capital to be accessed under this investment agreement.
SCOTT CORLETT, CEO OF EHOUSE GLOBAL, COMMENTED:
"The Company, its consultants, and service providers were all pleasantly surprised to have the S-1 go effective in such a quick manner. Typically OTC issuers see several rounds of in-depth questions or 'comments' lasting sometimes up to and over a year. We can only thank our Securities Attorneys at Szaferman Lakind as well as all of our other service providers for their tremendous job at providing adequate and accurate disclosure to the Commission."
"With these funds, the Company intends to make an initial inventory order of our NutraLiquids products, which the Company has just completed formulation of through several vendors in Southern California. Some of the more complex compounds and flavor profiles took longer to perfect than anticipated, but the Company is now very happy with the product to the point of which a production run is ready to be commissioned."
ABOUT EHOUSE GLOBAL (EHOS)
EHouse Global Inc., a publicly listed company under US ticker symbol: EHOS, is a consumer packaged goods brand accelerator developing its own products and actively pursuing international brands that fit its business model of natural, fair trade and environmentally friendly products with a commitment to conscious capitalism. For information about EHouse go to www.ehouse-global.com.
Through our wholly owned subsidiary NutraLiquids, our launch includes 16 different liquid nutritional products in single serving pouches with some products also available in 30 day supply, 30 ounce bottles. Each product is gluten-free and are loaded with vitamins, nutrients and natural ingredients proven to support each product's unique claim.
From Immunity Support to Weight loss, Omega 3 Heart Health, Detox, Energy, Sleep, Joint Support, Bone Health, Daily Vitamins and even Hangover prevention, we have created a wide variety of hot product segments for the large and growing nutrition industry and are poised for significant growth.
NOTICE REGARDING FORWARD-LOOKING STATEMENTS
This news release contains "forward-looking statements." Statements in this press release that are not purely historical are forward-looking statements and include any statements regarding beliefs, plans, expectations or intentions regarding the future. Such forward-looking statements include, among other things, the ability of the Company to reach its expansion goals and generate exciting new developments. Actual results could differ from those projected in any forward-looking statements due to numerous factors. Such factors include, among others, the inherent uncertainties associated with developing new products and operating as a development stage company, our ability to raise the additional funding we will need to continue to pursue our business and product development plans, competition in the industry in which we operate and market conditions. These forward-looking statements are made as of the date of this news release, and we assume no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those projected in the forward-looking statements, except as required by applicable law, including the securities laws of the United States. Although we believe that any beliefs, plans, expectations and intentions contained in this press release are reasonable, there can be no assurance that any such beliefs, plans, expectations or intentions will prove to be accurate. Investors should consult all of the information set forth herein and should also refer to the risk factors disclosure outlined in the reports and other documents we file with the SEC, available at www.sec.gov.